Medtronic Wins 501(K) Clearance for Sentrant Introducer Sheath
May 30, 2013 at 10:02 AM EDT
Medtronic, Inc. (NYSE: MDT ) is expanding its market-leading portfolio of products for endovascular aortic repair in the United States with two new medical devices: the company recently received approval from the U.S. Food and Drug Administration (FDA) for the Endurant II Aorto-Uni-Iliac (AUI) Stent Graft System and the FDA's 510(k) clearance for the
